EBS
Emergent Biosolutions
$7.33
+$0.07 (+0.96%)Jul 27, 2026
Key metrics
The numbers that frame EBS today
- Market cap
- $378.20M
- P/E (TTM)
- -44.0
- EV / FCF
- 5.8
- Gross margin
- 54.2%
- EV / Sales
- 1.2
- ROIC
- 5%
- Div yield
- 0%
- Debt / equity
- 1.1
- 52wk Low
- $5.62
- 52wk High
- $14.06
Growth
Revenue and earnings trend for EBS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about EBS
Is Emergent Biosolutions a good buy?
Hold. Emergent Biosolutions has excellent quality, but weak momentum makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Emergent Biosolutions is selling at a low price.
What is the market capitalization of EBS?
Emergent Biosolutions's market capitalization is $378.20M.
What is the P/E ratio for EBS stock?
Emergent Biosolutions's current P/E ratio is -44.
What is the 52-week high for EBS stock?
The 52-week high for Emergent Biosolutions is $14.06. The current close of $7.33 is 47.9% below that high.
What is the 52-week low for EBS stock?
The 52-week low for Emergent Biosolutions is $5.62. The current close of $7.33 is 30.4% above that low.
Does EBS stock pay dividends?
Emergent Biosolutions does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for EBS?
Emergent Biosolutions's Debt / Equity ratio is 1.1.